Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T08:15:56.021Z Has data issue: false hasContentIssue false

Management of Kell alloimmunized pregnancies

Published online by Cambridge University Press:  10 July 2002

Tatiana Freire-Lizama
Affiliation:
Department of Obstetrics and Gynecology, University of Toronto, Canada
Dick Oepkes
Affiliation:
Department of Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands

Abstract

Prevention programmes against Rh alloimmunization are now so widespread as to be universal in the developed world. Accordingly, there has been a dramatic decline in the incidence of fetal anaemia secondary to this cause, along with relative growth in the importance of alloimmunization due to other antibodies, particularly Kell. Antibodies to the Kell group of antigens, in particular K1, can cause profound fetal anaemia leading to hydrops and fetal demise unless appropriate and timely intervention is undertaken.

Type
Research Article
Copyright
© 2002 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)